Physician profile

Eric J Wasserman

Emergency Medicine · Toms River, NJ

NPI 1962500918

$1,053.97

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$288.62

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals Lp $405.59 2019-2023 Andexxa
Janssen Pharmaceuticals, INC $266.36 2019-2022
Allergan, INC. $151.63 2019-2020
Shionogi INC $78.12 2023 Fetroja
Inari Medical, INC. $43.00 2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Stryker Corporation $37.47 2019
Portola Pharmaceuticals, LLC $23.32 2019
Eisai INC. $18.96 2024
Csl Behring $15.20 2021
Acrotech Biopharma INC. $14.32 2024 Ryzneuta

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eric J Wasserman

$1,053.97

in general payments reported 2019-2025

Years
2019-2024
Top company
Astrazeneca Pharmaceuticals Lp

https://glasscript.com/doctor/88414/eric-j-wasserman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.